Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Sep;40(9):2015-2018.
doi: 10.1002/mds.30285. Epub 2025 Jul 9.

Evaluation of a Mitochondrial Polygenic Score for Parkinson's Disease Across Ancestries

Affiliations

Evaluation of a Mitochondrial Polygenic Score for Parkinson's Disease Across Ancestries

Joshua Chin Ern Ooi et al. Mov Disord. 2025 Sep.
No abstract available

Keywords: LRRK2; Parkinson's disease; mitochondria; mitochondrial polygenic score; polygenic score.

PubMed Disclaimer

Figures

FIG. 1
FIG. 1
Associations between mitochondrial polygenic scores (MGS) and Parkinson's disease (PD) status and age‐at‐onset (AAO). (A–C) Violin plots showing the distribution of standardized MGS for patients with idiopathic PD (iPD) and healthy individuals in the European (A) and Ashkenazi Jewish (B) ancestry groups, as well as for patients with LRRK2‐PD (C). Boxplots within the violins indicate the median (solid line) and interquartile range (box edges), while the violin shape reflects the overall data distribution. p = t‐test P‐value. (D–F): Receiver operating curves and respective area under the curve values for European (D) and Ashkenazi Jewish (E) ancestry groups, as well as patients with LRRK2‐PD (F). (G–I): Correlation plots displaying the association between MGS and AAO in patients with iPD in the European (G) and Ashkenazi Jewish (H) ancestry groups, as well as patients with LRRK2‐PD (I). r = Spearman's rank correlation coefficient, p = Spearman's exploratory P‐value. [Color figure can be viewed at wileyonlinelibrary.com]

Update of

References

    1. Billingsley KJ, Barbosa IA, Bandrés‐Ciga S, Quinn JP, Bubb VJ, Deshpande C, et al. Mitochondria function associated genes contribute to Parkinson's disease risk and later age at onset. NPJ Parkinsons Dis 2019;5(8):31123700. 10.1038/s41531-019-0080-x - DOI - PMC - PubMed
    1. Nalls MA, Blauwendraat C, Vallerga CL, Heilbron K, Bandres‐Ciga S, Chang D, et al. Identification of novel risk loci, causal insights, and heritable risk for Parkinson's disease: a meta‐analysis of genome‐wide association studies. Lancet Neurol 2019;18(12):1091–1102. 10.1016/S1474-4422(19)30320-5 - DOI - PMC - PubMed
    1. Lüth T, Gabbert C, Koch S, König IR, Caliebe A, Laabs BH, et al. Interaction of mitochondrial polygenic score and lifestyle factors in LRRK2 p.Gly2019Ser Parkinsonism. Mov Disord 2023;38(10):1837–1849. 10.1002/mds.29563 - DOI - PubMed
    1. Global Parkinson's Genetics Program , Nalls MA, Blauwendraat C, Bras J, Guerreiro R, Vallerga CL, et al. GP2: the global Parkinson's genetics program. Mov Disord 2021;36(4):842–851. 10.1002/mds.28494 - DOI - PMC - PubMed
    1. Rizig M, Bandres‐Ciga S, Makarious MB, Ojo OO, Crea PW, Abiodun OV, et al. Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome‐wide association study. Lancet Neurol 2023;22(11):1015–1025. 10.1016/S1474-4422(23)00283-1 - DOI - PMC - PubMed

LinkOut - more resources